These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 328225)

  • 1. Recovery of ovarian function after the use of a d-norgestrel-releasing IUD.
    Nilsson CG; Lähteenmäki P
    Contraception; 1977 Apr; 15(4):389-400. PubMed ID: 328225
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intrauterine progesterone-releasing devices on the hypothalamic-hypophyseal-ovarian axis in women.
    Carenza L; Ermini M; Pala A; Benagiano G
    Patol Clin Ostet Ginecol; 1976; 4(3):109-15. PubMed ID: 992205
    [No Abstract]   [Full Text] [Related]  

  • 4. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A D-norgestrel-releasing IUD.
    Nilsson CG; Johansson ED; Luukkainen T
    Contraception; 1976 Apr; 13(4):503-14. PubMed ID: 1253602
    [No Abstract]   [Full Text] [Related]  

  • 6. Immediate postabortal insertion of a levonorgestrel-releasing IUD.
    Heikkilä M; Lähteenmäki P; Luukkainen T
    Contraception; 1982 Sep; 26(3):245-59. PubMed ID: 6816506
    [No Abstract]   [Full Text] [Related]  

  • 7. Biodegradable polylactate as a steroid-releasing polymer: intrauterine administration of d-norgestrel.
    Nilsson CG; Johansson ED; Jackanicz TM; Luukkainen T
    Am J Obstet Gynecol; 1975 May; 122(1):90-5. PubMed ID: 1130448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal evaluation of the intrauterine progesterone contraceptive system.
    Bryand-Greenwood GD; Greenwood FC; Hale RW; Morishige WK
    J Clin Endocrinol Metab; 1977 Apr; 44(4):721-7. PubMed ID: 849982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of a d-norgestrel-releasing IUD.
    Nilsson CG
    Contraception; 1977 Mar; 15(3):295-306. PubMed ID: 880809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the human menstrual cycle.
    Jaffe RB
    Basic Life Sci; 1974; 4(PART A):371-83. PubMed ID: 4614789
    [No Abstract]   [Full Text] [Related]  

  • 11. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
    Hemrika DJ; Slaats EH; Schoemaker J
    Am J Obstet Gynecol; 1994 Feb; 170(2):462-8. PubMed ID: 8116698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function.
    Lähteenmäki P
    Acta Obstet Gynecol Scand Suppl; 1978; 76():1-43. PubMed ID: 696249
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative quantitation of menstrual blood loss with a d-norgestrel-releasing iud and a Nova-T-copper device.
    Nilsson CG
    Contraception; 1977 Apr; 15(4):379-87. PubMed ID: 880815
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles.
    Victor A; Johansson ED
    Contraception; 1976 Aug; 14(2):215-26. PubMed ID: 949897
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of NIH-LH on the ovary of immature rats under the influence of progesterone, norgestrel, and lynestrenol].
    Uhlarik A
    Experientia; 1972 Jan; 28(1):91-3. PubMed ID: 5062495
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of norgestrel administered intermittently on pituitary ovarian function.
    Craft I; Foss GL; Warren RJ; Fotherby K
    Contraception; 1975 Nov; 12(5):589-98. PubMed ID: 1192745
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of the ovary in controlling luteinizing hormone, follicle stimulating hormone, and prolactin secretion during and after lactation in pigs.
    Stevenson JS; Cox NM; Britt JH
    Biol Reprod; 1981 Mar; 24(2):341-53. PubMed ID: 6783136
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of norgestrel and metyrapone on pituitary-adrenal-ovarian function.
    Givens JR; Andersen RN; Ragland JB; Umstot ES
    Obstet Gynecol; 1976 Oct; 48(4):392-6. PubMed ID: 184406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-norgestrel slow-releasing T device as an intrauterine contraceptive.
    El-Mahgoub
    Am J Obstet Gynecol; 1975 Sep; 123(2):133-8. PubMed ID: 1163576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.